28/08/2023, 21:25
Anteris Heart Valve Draws Rivals in $10 Billion Market - Eureka Report
disallowed link/investment-news/anteris-heart-valve-draws-rivals-in-10-billion-market/152832 2/18
An endorsement by AK? (my bold below)...
"But look, they’re on the brink of selling this. More likely I think, as I put to
Wayne, that there’ll be an auction between the two competitors, which are Edwards and Medtronic, these are very large American companies that have got a product similar to this in the market that’s inferior to
Anteris’s, according to Wayne, but it sounds pretty right, and at some point they’ll probably compete to buy Anteris and it won’t be for $300 million, that’s for sure.
In the interview, Wayne says the net present value of the business is $US1.4 billion, but probably we’re talking multiples of that as the value of the company, so look, I think this is something you really should have a look at."
- Forums
- ASX - By Stock
- AVR
- Eureka report
AVR
anteris technologies global corp.
Add to My Watchlist
6.09%
!
$6.27

Eureka report, page-21
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.27 |
Change
0.360(6.09%) |
Mkt cap ! $97.17M |
Open | High | Low | Value | Volume |
$5.93 | $6.30 | $5.91 | $107.9K | 17.39K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | $6.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.27 | 200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | 6.120 |
1 | 2000 | 6.100 |
1 | 1250 | 5.950 |
1 | 857 | 5.830 |
1 | 900 | 5.780 |
Price($) | Vol. | No. |
---|---|---|
6.300 | 463 | 1 |
6.400 | 130 | 1 |
6.500 | 255 | 1 |
6.550 | 1092 | 1 |
6.600 | 320 | 1 |
Last trade - 15.42pm 27/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online